Title : Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI).

Pub. Date : 2020 Sep 30

PMID : 33007977






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Intercurrent steroids under ICI correlated with a shorter PFS/OS (1.3 and 2.3 mo. Steroids Moloney sarcoma oncogene Mus musculus
2 Steroid use for cancer-related symptoms was an independent prognostic factor for poor PFS [HR 2.64; 95% CI, 1.2-5.6] and OS [HR 4.53; 95% CI, 1.8-11.1], both p < 0.0001. Steroids Moloney sarcoma oncogene Mus musculus